Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Revenue (2020 - 2025)

Historic Revenue for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to $10.9 million.

  • IDEAYA Biosciences' Revenue rose 5537.14% to $10.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $218.7 million, marking a year-over-year increase of 302442.86%. This contributed to the annual value of $218.7 million for FY2025, which is 302442.86% up from last year.
  • Latest data reveals that IDEAYA Biosciences reported Revenue of $10.9 million as of Q4 2025, which was up 5537.14% from $207.8 million recorded in Q3 2025.
  • Over the past 5 years, IDEAYA Biosciences' Revenue peaked at $207.8 million during Q3 2025, and registered a low of $3.0 million during Q4 2021.
  • Over the past 5 years, IDEAYA Biosciences' median Revenue value was $7.9 million (recorded in 2023), while the average stood at $21.9 million.
  • Its Revenue has fluctuated over the past 5 years, first soared by 23087.12% in 2022, then tumbled by 7293.51% in 2023.
  • Over the past 5 years, IDEAYA Biosciences' Revenue (Quarter) stood at $3.0 million in 2021, then surged by 35.79% to $4.0 million in 2022, then fell by 2.49% to $3.9 million in 2023, then skyrocketed by 78.48% to $7.0 million in 2024, then skyrocketed by 55.37% to $10.9 million in 2025.
  • Its Revenue stands at $10.9 million for Q4 2025, versus $207.8 million for Q3 2025 and $7.0 million for Q4 2024.